259 related articles for article (PubMed ID: 25823500)
1. Advantages of fecal lactoferrin measurement during granulocyte and monocyte adsorptive apheresis therapy in ulcerative colitis.
Hashiguchi K; Takeshima F; Akazawa Y; Matsushima K; Minami H; Machida H; Yamaguchi N; Shiozawa K; Ohba K; Ohnita K; Ichikawa T; Isomoto H; Nakao K
Digestion; 2015; 91(3):208-17. PubMed ID: 25823500
[TBL] [Abstract][Full Text] [Related]
2. Faecal lactoferrin is a useful biomarker for mucosal healing in patients with ulcerative colitis during granulocyte and monocyte adsorptive apheresis therapy.
Sagawa T; Kakizaki S; Tomizawa T; Nakayama T; Tanaka H; Tojima H; Sato K; Kusano M; Okamura S; Yamada M
Colorectal Dis; 2016 Jul; 18(7):696-702. PubMed ID: 26748553
[TBL] [Abstract][Full Text] [Related]
3. An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment.
Sakuraba A; Motoya S; Watanabe K; Nishishita M; Kanke K; Matsui T; Suzuki Y; Oshima T; Kunisaki R; Matsumoto T; Hanai H; Fukunaga K; Yoshimura N; Chiba T; Funakoshi S; Aoyama N; Andoh A; Nakase H; Mizuta Y; Suzuki R; Akamatsu T; Iizuka M; Ashida T; Hibi T
Am J Gastroenterol; 2009 Dec; 104(12):2990-5. PubMed ID: 19724269
[TBL] [Abstract][Full Text] [Related]
4. Fecal calprotectin is a useful biomarker for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis in ulcerative colitis patients: a prospective observation study.
Ueno N; Sugiyama Y; Kobayashi Y; Murakami Y; Iwama T; Sasaki T; Kunogi T; Takahashi K; Tanaka K; Ando K; Kashima S; Inaba Y; Moriichi K; Tanabe H; Taruishi M; Saitoh Y; Okumura T; Fujiya M
BMC Gastroenterol; 2021 Aug; 21(1):316. PubMed ID: 34362299
[TBL] [Abstract][Full Text] [Related]
5. Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA.
Yokoyama Y; Kawai M; Fukunaga K; Kamikozuru K; Nagase K; Nogami K; Kono T; Ohda Y; Iimuro M; Hida N; Nakamura S; Miwa H; Matsumoto T
BMC Gastroenterol; 2013 Feb; 13():27. PubMed ID: 23399416
[TBL] [Abstract][Full Text] [Related]
6. Relevance of the processed blood volume per granulocyte and monocyte apheresis session to its clinical efficacy in patients with ulcerative colitis.
Kikuyama R; Fukunaga K; Kawai M; Yokoyama Y; Kamikozuru K; Hida N; Ohda Y; Takeda N; Yoshida K; Iimuro M; Kato K; Kono T; Nogami K; Nagase K; Nakamura S; Takei Y; Miwa H; Matsumoto T
Ther Apher Dial; 2011 Aug; 15(4):360-6. PubMed ID: 21884470
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with treatment outcome, and long-term prognosis of patients with ulcerative colitis undergoing selective depletion of myeloid lineage leucocytes: a prospective multicenter study.
Yokoyama Y; Watanabe K; Ito H; Nishishita M; Sawada K; Okuyama Y; Okazaki K; Fujii H; Nakase H; Masuda T; Fukunaga K; Andoh A; Nakamura S
Cytotherapy; 2015 May; 17(5):680-8. PubMed ID: 25804800
[TBL] [Abstract][Full Text] [Related]
8. Ulcerative colitis with hepatitis B virus infection treated successfully by granulocyte monocyte apheresis.
Saito H; Hanafusa N; Kishikawa J; Noiri E; Sunami E; Ishihara S; Watanabe T; Nangaku M
J Clin Apher; 2016 Dec; 31(6):584-586. PubMed ID: 26876484
[TBL] [Abstract][Full Text] [Related]
9. Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.
Schultheiß C; Weischenberg R; Herrmann A; Haller B; Schmid RM; Reindl W; Huber W
Artif Organs; 2015 Feb; 39(2):187-92. PubMed ID: 24981894
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte and monocyte adsorption apheresis therapy modulates monocyte-derived dendritic cell function in patients with ulcerative colitis.
Iwakami Y; Sakuraba A; Sato T; Takada Y; Izumiya M; Ichikawa H; Hibi T
Ther Apher Dial; 2009 Apr; 13(2):138-46. PubMed ID: 19379153
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Usefulness of New Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis in Active Ulcerative Colitis Patients Without Corticosteroids and Biologics.
Shimazu K; Fukuchi T; Kim I; Noguchi Y; Iwata M; Koyama S; Ubukata S; Tanaka A
Ther Apher Dial; 2016 Aug; 20(4):383-9. PubMed ID: 27523079
[TBL] [Abstract][Full Text] [Related]
13. Targeting neutrophils in inflammatory bowel disease: revisiting the role of adsorptive granulocyte and monocyte apheresis.
Bamias G; Zampeli E; Domènech E
Expert Rev Gastroenterol Hepatol; 2022 Aug; 16(8):721-735. PubMed ID: 35833363
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis.
Yamamoto T; Umegae S; Matsumoto K
J Crohns Colitis; 2012 Aug; 6(7):750-5. PubMed ID: 22398094
[TBL] [Abstract][Full Text] [Related]
15. The effect of granulocyte and monocyte adsorptive apheresis on serum cytokine levels in patients with ulcerative colitis.
Toya Y; Chiba T; Mizutani T; Sato K; Kasugai S; Matsuda N; Orikasa S; Shibata S; Abiko Y; Akasaka R; Yokoyama N; Oana S; Hirota S; Endo M; Suzuki K
Cytokine; 2013 Apr; 62(1):146-50. PubMed ID: 23465691
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study.
Ishiguro Y; Ohmori T; Umemura K; Iizuka M
Ther Apher Dial; 2021 Aug; 25(4):502-512. PubMed ID: 33029920
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA and granulocyte-monocyte adsorption apheresis combotherapy after inadequate response to anti-TNF agents in ulcerative colitis.
Sáez-González E; Moret-Tatay I; Bastida G; Aguas M; Iborra M; Nos P; Beltrán B
J Clin Apher; 2024 Feb; 39(1):e22101. PubMed ID: 38054256
[TBL] [Abstract][Full Text] [Related]
18. Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis.
Andoh A; Tsujikawa T; Inatomi O; Deguchi Y; Hata K; Kitoh K; Sasaki M; Mitsuyama K; Fujiyama Y
Ther Apher Dial; 2005 Apr; 9(2):123-7. PubMed ID: 15828923
[TBL] [Abstract][Full Text] [Related]
19. Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.
Yoshino T; Nakase H; Matsuura M; Matsumura K; Honzawa Y; Fukuchi T; Watanabe K; Murano M; Tsujikawa T; Fukunaga K; Matsumoto T; Chiba T
Digestion; 2011; 84(1):3-9. PubMed ID: 21311190
[TBL] [Abstract][Full Text] [Related]
20. Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis.
Hanai H; Watanabe F; Yamada M; Sato Y; Takeuchi K; Iida T; Tozawa K; Tanaka T; Maruyama Y; Matsushita I; Iwaoka Y; Kikuch K; Saniabadi AR
Digestion; 2004; 70(1):36-44. PubMed ID: 15297776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
